Characterization and antibacterial action mode of bacteriocin BMP32r and its application as antimicrobial agent for the therapy of multidrug-resistant bacterial infection
Authors:
- 1 December 2020
- journal article
- research article
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 164, 845-854
Abstract
No abstract availableKeywords
Funding Information
- Special Fund for Agro-scientific Research in the Public Interest (201503135)
This publication has 52 references indexed in Scilit:
- Isolation and characterisation of a new antimicrobial peptide from the skin of Xenopus laevisInternational Journal of Antimicrobial Agents, 2011
- Factors Affecting Wound HealingJournal of Dental Research, 2010
- Class II one-peptide bacteriocins target a phylogenetically defined subgroup of mannose phosphotransferase systems on sensitive cellsMicrobiology, 2009
- Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2009
- Escherichia coli Peptidase A, B, or N Can Process Translation Inhibitor Microcin CJournal of Bacteriology, 2008
- Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substancesNature Protocols, 2008
- The action of the bacterial toxin, microcin B17, on DNA gyraseBiochimie, 2007
- Bacteriocins: developing innate immunity for foodNature Reviews Microbiology, 2005
- Enterolysin A, a Cell Wall-Degrading Bacteriocin fromEnterococcus faecalisLMG 2333Applied and Environmental Microbiology, 2003
- Bacteriocins: Evolution, Ecology, and ApplicationAnnual Review of Microbiology, 2002